The OUTREACH Study – Demonstrating that CAR-T therapies can be effectively administered in community cancer settings: In the ...

Boehringer Ingelheim, one of the industry leading investors in research and development in innovative life expectancy therapies, announced a $105 million (€90 million) global license and transfer ...

Willis Chandler is the new president and CEO of Knipper Health. The news came alongside the announcement that Frazier ...

Approval of Kerendia was based on results from the Phase III FINEARTS-HF trial, which demonstrated statistically significant ...

A panel of key opinion leaders consider how payers and manufacturers are increasingly embracing innovative contracting models ...

The new drug application is supported by 48-week data from the Phase III MK-8591A-051 and MK-8591A-052 trials, which showed ...

The majority of respondents not already enrolled in the program have concerns that the program won’t survive until the point ...

The specific parameters defined in your label, including patient population, line of therapy, and outcomes measured, will now ...

Bravecto Quantum is the first FDA-approved drug that treats and prevents flea and tick infestations on dogs for a duration of ...

rs6190 helps men build muscle mass and reduce diabetes risk, but increases cholesterol levels and elevates the risk of ...

Renee Gala named next CEO of Jazz Pharmaceuticals: Gala will take over as president and CEO on August 11, 2025, following ...

The new doll will include an insulin pump, a glucose monitor, and a dress featuring international symbols for diabetes ...